Document Detail


Utilization of advanced modalities in the management of diabetic Charcot neuroarthropathy.
MedLine Citation:
PMID:  20920430     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Technological advances have allowed reconstructive foot and ankle surgeons greater opportunity to provide significant limb salvage options to those patients who present with significant lower extremity deformity due to diabetic Charcot neuroarthropathy. Paradigms that promote the utilization of these advanced modalities have demonstrated significant improved limb salvage outcomes in this challenging patient population and have consequently improved the quality of life for patients. The purpose of this review is to discuss current concepts in Charcot reconstruction.
Authors:
Jennifer Pappalardo; Ryan Fitzgerald
Publication Detail:
Type:  Journal Article; Review     Date:  2010-09-01
Journal Detail:
Title:  Journal of diabetes science and technology     Volume:  4     ISSN:  1932-2968     ISO Abbreviation:  J Diabetes Sci Technol     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-10-05     Completed Date:  2011-02-10     Revised Date:  2011-09-13    
Medline Journal Info:
Nlm Unique ID:  101306166     Medline TA:  J Diabetes Sci Technol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1114-20     Citation Subset:  IM    
Copyright Information:
© 2010 Diabetes Technology Society.
Affiliation:
St. Vincent Hospital/UMASS Memorial Hospital, Worcester, Massachusetts, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arthropathy, Neurogenic / etiology,  surgery*
Diabetes Complications / complications*
Electromagnetic Phenomena
Humans
Limb Salvage / methods,  trends*
Platelet-Rich Plasma
Restraint, Physical / methods
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hyperspectral imaging in diabetic foot wound care.
Next Document:  Novel use of platelet-rich plasma to augment curative diabetic foot surgery.